When comparing GLP-1 receptor agonists available in the UK, semaglutide (Ozempic, Wegovy, Rybelsus), dulaglutide (Trulicity), liraglutide (Victoza, Saxenda), exenatide (Byetta, Bydureon), and lixisenatide (Lyxumia) each demonstrate different nausea profiles based on clinical trial evidence and real-world data
Multi-pathway Action: Unlike Semaglutide, Retatrutide taps into multiple hormonal circuits
In addition to injectable options, there is also an oral form of GLP-1 therapy available
Healthspan is HIPAA-compliant and uses encrypted systems to protect your medical and personal data at every step
The dizziness some people experience on semaglutide can become severe with accidental double dosing
Then you will receive a report sent to your email that will help you understand your options for GLP-1 treatment